Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02256930 · ClinicalTrials.gov registry record · Phase 1
Skin Safety Study to Evaluate the Sensitizing Potential in Healthy Volunteers
A Phase 1 study of Healthy Volunteers, sponsored by Maruho North America.
- Completed
- Registry status
- Phase 1
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT02256930 is a Phase 1 study of Healthy Volunteers that has completed, run by Maruho North America. The registered enrollment target is 240 participants, below the 481-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02256930, a Phase 1 study of Healthy Volunteers, has completed, sponsored by Maruho North America.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single center, randomized, controlled, within subject comparison, multiple dose study to determine the sensitization potential of M518101 on normal skin under occlusive patch condition.
Conditions Studied
Interventions
- OTHER Saline
- DRUG M518101
- DRUG M518101 Vehicle
- OTHER Sodium lauryl sulfate
Study Locations (1)
New Jersey
- TKL research - Fair Lawn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02256930
The ClinicalTrials.gov registry entry for NCT02256930 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 481-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (50% lower). The listed sponsor is Maruho North America, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Volunteers appearing as the primary indexed condition, and to 4 interventions - of which Saline is the first listed.
NCT02256930 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT02256930 about?
NCT02256930 is a clinical study titled "Skin Safety Study to Evaluate the Sensitizing Potential in Healthy Volunteers". This is a single center, randomized, controlled, within subject comparison, multiple dose study to determine the sensitization potential of M518101 on normal skin under occlusive patch condition.
What is the current status of trial NCT02256930?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 240 participants. The study started on 2014-09. Estimated completion is 2015-08.
What conditions does trial NCT02256930 study?
This clinical trial studies the following conditions: Healthy Volunteers.
What interventions are being tested in trial NCT02256930?
The interventions under investigation include: Saline (OTHER), M518101 (DRUG), M518101 Vehicle (DRUG), Sodium lauryl sulfate (OTHER).
Who is sponsoring clinical trial NCT02256930?
This trial is sponsored by Maruho North America, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02256930 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia
RECRUITING · Phase 1
-
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.
RECRUITING · Phase 1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult Participants
RECRUITING · Phase 1
-
A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.
RECRUITING · Phase 1
-
Classroom Break, Cognition, and Fitness in Elementary School Children
RECRUITING · Phase 1
-
A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.